Order
      
      827014-71-1
      
        Acetamide,N-[[(5S)-3-[4-[(1a,5a,6b)-6-cyanobicyclo[3.1.0]hex-6-yl]phenyl]-2-oxo-5-oxazolidinyl]methyl]-
      
    
    
    
    
    
      
        Order
      
      826995-00-0
      
        2-Hexenedioic acid, 4-methyl-,6-[(1S,2R,3E)-2,4-dimethyl-1-(2-oxopropyl)-6-[(2S,3R,5R)-tetrahydro-3-[(4-methoxyphenyl)methoxy]-5-methyl-5-propyl-2-furanyl]-3-hexenyl]ester, (2E,4S)-
      
    
    
      
        Order
      
      826995-20-4
      
        Benzenemethanol,2-hydroxy-5-methyl-3-[[(1-methylethyl)[(1-methyl-1H-imidazol-2-yl)methyl]amino]methyl]-
      
    
    
    
    
    
    
    
    
      
        Order
      
      826995-18-0
      
        Glycine,N,N'-[(2-hydroxy-5-methyl-1,3-phenylene)bis(methylene)]bis[N-[(1-methyl-1H-imidazol-2-yl)methyl]-, diethyl ester
      
    
    
    
    
    
                    
  
  
  
  
  
  
  
  
                826995-00-0,826995-08-8,826995-18-0,826995-20-4,826995-50-0,826995-53-3 Supplier | KINGPHARM.GROUP
            CMO CDMO service. KINGPHARM.GROUP supply 826995-00-0,826995-08-8,826995-18-0,826995-20-4,826995-50-0,826995-53-3 and related compounds.
            
                    826995-08-8
                    826995-18-0
                    826995-00-0
                    826995-20-4
                    826995-53-3
                    826995-50-0